Enzo Biochem, Inc. operates within the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Enzo Biochem with three other
pharmaceutical manufacturers in North America:
OrganiGram Holdings Inc
of Canada
(2019
sales of 80.41 million Canadian Dollars [US$60.64 million]
),
Palatin Technologies, Inc.
($60.30 million
of which 100%
was Licenses, Grants and Contracts), and
Summit Therapeutics PLC
($56.84 million
of which 100%
was Drug Discovery).
Sales Analysis.
During the year ended July of 2019, sales at
Enzo Biochem were $81.17 million.
This
is
a
decrease of 22.5%
versus 2018, when the company's sales were $104.71 million.
Contributing to the drop in overall sales was the 31.6% decline
in Clinical Laboratory Services, from $74.78 million to $51.12 million.
.
However, these declines were partially offset by the increase in sales of
Life Sciences Products (up 0.4% to $30.06 million)
.